The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.

 
Web www.patentalert.com

< Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase

< Gastrointestinal proliferative factor and uses thereof

> Selective androgen receptor modulators and methods for their identification, design and use

> Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds
~ 00221